Principal Financial Group Inc Ovid Therapeutics Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$3.13 - $3.73 $39,431 - $46,990	-12,598 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$3.31 - $4.04 $6,762 - $8,253	-2,043 Reduced 13.95%	12,598 $42,000
Q2 2021 Aug 10, 2021	BUY	$3.3 - $4.49 $1,867 - $2,541	566 Added 4.02%	14,641 $57,000
Q1 2021 May 10, 2021	SELL	$2.42 - $4.47 $25,516 - $47,131	-10,544 Reduced 42.83%	14,075 $57,000
Q4 2020 Feb 08, 2021	BUY	$2.28 - $6.84 $56,131 - $168,393	24,619 New	24,619 $57,000

33.2M

15.6K

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $98.6M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.